Large Volume Wearable Injectors, also known as bolus injectors or non-insulin patch pumps, are drug delivery devices that have above 1 ml capacity of injectable volume. These devices can offer a range of benefits to patients, for example, to make administration more convenient and reduce patient suffering.
In the coming years there is an increasing demand for Large Volume Wearable Injectors in the regions of US and Europe that is expected to drive the market for more advanced Large Volume Wearable Injectors. Increasing of the cancer, auto-immune, blood disorders and stable rise in aging population will drive growth in United States and Europe markets.
Globally, the Large Volume Wearable Injectors industry market is concentrated as the manufacturing technology of Large Volume Wearable Injectors is relatively matures than some high-tech equipment. And some enterprises, like West, Unilife, CeQur, etc. are well-known for the wonderful performance of their Large Volume Wearable Injectors and related services. At the same time, United States, occupied 64.61% production market share in 2015, is remarkable in the global Large Volume Wearable Injectors industry because of their market share and technology status of Large Volume Wearable Injectors.
The consumption volume of Large Volume Wearable Injectors is related to downstream industries and global economy. As there will always be some uncertain in the global economy in the following years, the growth rate of Large Volume Wearable Injectors industry may not keep that fast. But it is surely forecasted that the market of Large Volume Wearable Injectors is still promising.
The global Large Volume Wearable Injectors market is valued at 35 million US$ in 2018 and will reach 33100 million US$ by the end of 2025, growing at a CAGR of 135.8% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Large Volume Wearable Injectors market based on company, product type, end user and key regions.
This report studies the global market size of Large Volume Wearable Injectors in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Large Volume Wearable Injectors in these regions.
This research report categorizes the global Large Volume Wearable Injectors market by top players/brands, region, type and end user. This report also studies the global Large Volume Wearable Injectors market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
J & J
Market size by Product
Market size by End User
Blood Disorders Treatment
Market size by Region
Central & South America
Rest of Central & South America
Middle East & Africa
The study objectives of this report are:
To study and analyze the global Large Volume Wearable Injectors market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Large Volume Wearable Injectors market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Large Volume Wearable Injectors companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Large Volume Wearable Injectors submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Large Volume Wearable Injectors are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Large Volume Wearable Injectors market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.